A Study Evaluating the Efficacy and Safety of ZG005 in Combination With Donafenib Tosilate Tablets or Bevacizumab as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma
Latest Information Update: 06 Feb 2024
At a glance
- Drugs Bevacizumab (Primary) ; Donafenib (Primary) ; ZG-005 (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
Most Recent Events
- 06 Feb 2024 New trial record